Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) have received a consensus rating of “N/A” from the zero research firms that are covering the stock, MarketBeat Ratings reports. NMRA has been the subject of a number of research reports. Royal Bank of Canada assumed coverage on Neumora Therapeutics in a research note on […]